Saqib Islam's Net Worth
$37.7 Million
Who is Saqib Islam?
Saqib Islam has an estimated net worth of $37.7 Million. This is based on reported shares across multiple companies, which include ARYA Sciences Acquisition Corp III, SpringWorks Therapeutics, Inc., ARS Pharmaceuticals, Inc., Passage BIO, Inc., and ALEXION PHARMACEUTICALS INC.
SEC CIK
Saqib Islam's CIK is 0001575408
Past Insider Trading and Trends
2023 was Saqib Islam's most active year for acquiring shares with 5 total transactions. Saqib Islam's most active month to acquire stocks was the month of December. 2016 was Saqib Islam's most active year for disposing of shares, totalling 9 transactions. Saqib Islam's most active month to dispose stocks was the month of January. 2013 saw Saqib Islam paying a total of $6,692,250.00 for 100,000 shares, this is the most they've acquired in one year. In 2014 Saqib Islam cashed out on 56,250 shares for a total of $7,867,424.95, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ARYA Sciences Acquisition Corp III (NAUT) Snapshot price: $2.67
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SpringWorks Therapeutics, Inc. (SWTX) Snapshot price: $49.07
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +28.74% | 57.21K |
$40.04 | -$1,232,667.72 | 256.26K |
Jan 4 - Jan 8
| |||
Form 4
|
∞
| 199.05K |
—
|
—
| 199.05K |
Nov 30
| |||
Form 4
| -0.45% | -4.10K |
$26.41 | -$108,201.77 | 905.1K |
Jan 7
| |||
Form 4
| +9.09% | 75.78K |
$27.52 | -$231,168.00 | 909.2K |
Jan 5 - Jan 6
| |||
Form 4/A
| -0.47% | -4.00K |
$56.06 | -$224,015.76 | 853.59K |
Jan 7
| |||
Form 4
| -0.69% | -5.89K |
$56.06 | -$330,361.58 | 851.7K |
Jan 7
| |||
Form 4
| +10.06% | 78.37K |
—
|
—
| 857.59K |
Jan 6
| |||
Form 4
| -1.28% | -10.08K |
$58.67 | -$591,527.26 | 779.22K |
Scheduled
|
Oct 20
| ||
Form 4
| -6.38% | -52.42K |
$58.65 | -$3,074,378.06 | 769.13K |
Scheduled
|
Oct 18 - Oct 19
| ||
Form 4
| -7.07% | -62.50K |
$76.56 | -$4,785,188.55 | 821.55K |
Scheduled
|
Jul 19 - Jul 20
| ||
Form 4
| -6.60% | -62.50K |
$68.02 | -$4,251,106.48 | 884.05K |
Scheduled
|
Apr 19 - Apr 20
| ||
Form 4
| -4.86% | -62.50K |
$78.55 | -$4,909,389.65 | 1.22M |
Scheduled
|
Jan 19 - Jan 20
| ||
Form 4
| +3.00% | 37.5K |
—
|
—
| 1.29M |
Jan 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARS Pharmaceuticals, Inc. (SPRY) Snapshot price: $6.31
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Passage BIO, Inc. (PASG) Snapshot price: $0.9972
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 27
| |||
Form 4
|
∞
| 5K |
$18.00 | $90,000.00 | 5K |
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALEXION PHARMACEUTICALS INC No price found
EVP, Chief Strat & Port. Off.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.02% | -905.00 |
$138.91 | -$125,713.55 | 43.8K |
Feb 29
| |||
Form 4
| +22.86% | 8.32K |
$141.17 | -$486,179.34 | 44.7K |
Feb 4 - Feb 8
| |||
Form 4
| -2.54% | -950.00 |
$190.00 | -$180,500.00 | 36.38K |
Scheduled
|
Dec 8
| ||
Form 4
| -2.55% | -975.00 |
$180.00 | -$175,500.00 | 37.34K |
Scheduled
|
Nov 2
| ||
Form 4
| -3.91% | -1.56K |
$168.44 | -$262,429.52 | 38.31K |
Oct 26
| |||
Form 4
| -13.14% | -6.03K |
$181.57 | -$1,095,230.24 | 39.87K |
Apr 27
| |||
Form 4
| +14.10% | 4.87K |
$180.34 | -$41,117.52 | 39.43K |
Feb 27 - Mar 2
| |||
Form 4
| -4.16% | -1.50K |
$171.15 | -$256,725.00 | 34.56K |
Feb 10
| |||
Form 4
| +32.09% | 8.76K |
—
|
—
| 36.06K |
Feb 5
| |||
Form 4
|
—
|
0
|
$139.87 | -$2,848,237.45 | 27.3K |
Nov 3
| |||
Form 4
| +9.20% | 2.3K |
—
|
—
| 27.3K |
Feb 28
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Apr 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||